Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FPRL7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,414.50 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. This delivery order, issued on September 12, 2025, is expected to be completed by October 3, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. The award was made without a specific set-aside designation, allowing the woman-owned small business to compete directly in the open market.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler registered in SAM.gov since 2001, has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering branded and generic prescription drugs, biologics, medical consumables, and specialty pharmaceuticals across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FPRL7?
SPE2DB25FPRL7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FPRL7 worth?
The government has obligated $10,415 on SPE2DB25FPRL7.
Is contract SPE2DB25FPRL7 an order under another contract?
Yes. SPE2DB25FPRL7 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRL7 competed?
The extent of competition for SPE2DB25FPRL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award